Intracranial Pressure (ICP) Monitoring Market Size 2020: Global Market Size, Competitive Landscape, and Key Country Analysis to 2024

 Intracranial Pressure (ICP) Monitoring Market Research Report: Information by Route of Intervention (Intraventricular and Epidural Sensor), Technique (Invasive and Non-Invasive), Application (Traumatic Brain Injury and Subarachnoid Hemorrhage), Device (Intraventricular Catheter and Epidural Sensors), End-User (Hospitals and Clinics, Trauma Centers and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Global Forecast Till 2024

Overview

The Global Intracranial Pressure (ICP) Monitoring Market is expected to exhibit a strong 7.1% CAGR over the forecast period from 2018 to 2024, according to the latest research report from Market Research Future (MRFR). The global intracranial pressure monitoring market is mainly driven by the growing demand for noninvasive tools in the field of ICP monitoring and the increasing awareness about the importance of intracranial pressure monitoring in containing and managing neural and skeletal damage.

Competitive Analysis:

Leading players in the global intracranial pressure monitoring market include DePuy Synthes, Terumo Corporation, Spiegelberg GmbH & Co. KG, RAUMEDIC Inc., Boston Neurosciences, Medtronic plc, Integra LifeSciences Corporation, Sophysa SA, and Natus Medical Inc.

• In August 2019, Integra completed the acquisition of Arkis Biosciences, a leading player in the neurosurgery devices market.

Regional Analysis:

Americas held a dominant 41.4% share in the global intracranial pressure monitoring market in 2017 and are likely to hold on to the lead in the global intracranial pressure monitoring market over the forecast period due to the increasing demand for effective intracranial pressure monitoring devices in North America. Widespread awareness about the importance of intracranial pressure monitoring in North America, particularly the U.S. and Canada, is likely to remain a major driver for the intracranial pressure monitoring market in the Americas over the forecast period. Intracranial pressure monitoring is mainly used in the management of brain trauma and skeletal hemorrhage. The rising prevalence of both these target conditions in North America is likely to remain a major driver for the intracranial pressure monitoring market in the region over the forecast period.

Europe is also likely to hold a significant share in the global intracranial pressure monitoring market over the forecast period due to the increasing awareness about the process and the relevance of the monitoring in medical diagnosis and trauma management. Intensive efforts at trauma control and management in European countries are likely to be a major driver for the intracranial pressure monitoring market in the region over the forecast period. The growing demand for noninvasive intracranial pressure monitoring tools in Europe and North America is also likely to be a major driver for the market, as the healthcare sector in these advanced regions is transitioning towards noninvasive medical tests, leading to a corresponding increase in the demand for noninvasive tools and technologies from the medical devices sector. Despite the increasing awareness about the inefficacy of noninvasive testing in intracranial pressure monitoring, the demand for product innovations aiming at making noninvasive intracranial pressure monitoring more accurate and on par with invasive monitoring is likely to remain a major driver for the intracranial pressure monitoring market in North America and Europe over the forecast period.

Asia Pacific is also likely to exhibit steady growth in the global intracranial pressure monitoring market over the forecast period, though the region is not likely to overtake North America or Europe as the leading regional markets for intracranial pressure monitoring devices in the coming years. Increasing awareness about the importance of intracranial pressure monitoring in trauma management is likely to be a major driver for the intracranial pressure monitoring market in Asia Pacific over the forecast period.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/intracranial-pressure-monitoring-market-703

About Market Research Future: 

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Covid19 Impact on Swollen Knee Treatment Market Counting 7.4% CAGR up to 2023 | by Technology; Digital mammography, 3D mammography, C-View 2D and others

 Market Highlights

A swollen knee arises when surplus fluid accumulates in or around your knee joint. It is also called as “water on the knee” and “knee effusion”. A swollen knee may be a consequence of overuse injuries, or trauma, and an underlying disease or condition. According to the American Academy of Orthopedic Surgeons, the total knee replacement surgeries is projected to grow by 3.5 million procedures per year by 2030. The swollen knee treatment market is anticipated to grow due to the rise in geriatric population, obesity, arthritis, and others. Serious complications such as blood clots, knee joint infections can be restraining factors for the growth of the market.

Segmentation

The global swollen knee treatment market has been segmented on the basis of type and end-users. On the basis of type, the market has been classified as medications, patient-controlled analgesia (PCA) pumps, nerve blocks, liposomal bupivacaine, and surgery. The medications have been segmented into opioids and corticosteroids and others. The surgery is segmented into arthrocentesis, arthroscopy and knee replacement. The knee replacement is further segmented into total knee replacement, unicompartmental knee replacement, and others. On the basis of end-users, the market has been classified as hospitals, clinics, ambulatory surgery centers, and others.

Access Report @ https://www.marketresearchfuture.com/reports/swollen-knee-treatment-market-6406

Regional Analysis

The Americas is projected to lead the swollen knee treatment market in the forecast period. Rising rate in a number of surgeries due to factors such as accidents, injuries, and others contribute majorly to the growth of the market. Increasing healthcare awareness, advancement in technology, medical tourism, and an increase in disposable income are some other factors that boost the growth of the market.

The European market is expected to hold the second largest market share as osteoarthritis is most common in Germany. The European market is projected to grow because of the increase in elderly population, growing prevalence of diabetes, and obesity in the region.

Asia-Pacific was projected to be the fastest growing region for the global swollen knee treatment market. The market is expected to witness growth owing to the rising patient population, changing lifestyle, and growing elderly population. This is expected to provide favorable backgrounds for the market to grow.

The Middle East and Africa accounts for the least share due to stringent government policies and low per capita income.

Key Players

Some of the key players in the global swollen knee treatment market share are Stryker Corporation, Zimmer Holdings, Smith & Nephew Plc., DePuy Companies Inc., Wright Medical Group Inc., Biomet Inc., Exactech, B. Braun Melsungen AG, Pfizer Pharmaceuticals Inc., Merck & Co., Fresenius Kabi, AngioDynamics , C.R.Bard ,Teleflex, and Smiths Medical

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Research On Neurovascular Devices Market 2018 - Size,Share Top Leaders and Demand

 Global Market for Neurovascular Devices to Exhibit an Above-Average Growth over the Next Six Years 

Neurovascular devices are increasingly being used in for treating and management of neurovascular disorders such as arteriovenous malformations (AVMs) and brain aneurysm. As the global burden of neurovascular disorders continue to rise, the demand for their treatments gains further traction. Neurovascular disease are complex in nature and hence preference for minimally invasive procedures is higher. This, in turn, is driving the sales of neurovascular devices across the globe. Market Research Future (FRMR) is its latest report asserts that the global neurovascular devices Market will grow at a healthy rate over the next couple of years.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/5544  

Incessant product innovation, increased product marketing and favourable reimbursement policies are driving the global market for neurovascular devices. Other factors that are reflecting favourably on the market include expansion of the geriatric population, and advances in medical technology in the field of interventional neurology.  Moreover, neurovascular devices are also used in treating patients suffering for ischemic stroke or haemorrhagic. It has been observed that neurovascular device assisted interventional procedures are replacing the traditional neurosurgeries. Owing the low risk of damaging surrounding tissues and minimal surgical trauma, interventional procedure are more favoured as compared to neurosurgery. At the same time, chances of infection is significantly when neurovascular device based treatment. On the other hand, inadequate number of hilly skilled neurologist, particularly in developing countries expected to have a negative impact on the growth of the market. High cost of neurovascular devices continue to limit their user base despite their increased efficiency.

Latest Industry Highlights:

• Perflow Medical, a renowned medical devices manufacturing company based in Israel, which is primarily engaged in developing novel solution for neurovascular interventions. Has recently announced that the company successfully approved a $12 Mn funding from its investors. Reportedly, the funding syndicate in included two new international investors with the existing stakeholders. 

• Junkosha a US-based company has recently introduced a unique peelable heat shrink. The technology will reportedly enable access to intricate parts of the vascular system with minimal risk of damage to the surroundings. 

Global Market for Neurovascular Devices – Segmental Analysis 

MRFR in its report has offer comprehensive segmental analysis of the market based on therapeutic application, end-user and product. By therapeutic application, the market is bifurcated into ischemic strokes and hemorrhagic stroke. Based on end user, the market is segment into ambulatory surgical units and hospitals & clinics. By product type, the market is segmented into stenting systems, neurothrombectomy devices, cerebral balloon angioplasty, aneurysm coiling & embolization devices and support device. 

Regional Overview 

The Americas is expected to hold the dominant position in the global market for neurovascular devices. This is primarily attributed to the rising incidences of neurovascular disorders such as arteriovenous malformations (AVMs) and brain aneurysm across North and South America. In addition, presence of major players and rising healthcare spending among Americans is propelling the market in the region. Improved reimbursement scenario and rapid adoption of neurovascular devices in neurological centers across the region is also proving an impetus to the market. Asia Pacific and Europe are two other regions anticipated to present significant growth opportunities for market during the forecast period.

Global Market for Neurovascular Devices – Competitive Analysis

Leading companies operating in the global market for neurovascular devices include Medtronic, TERUMO CORPORATION, Merit Medical Systems, Inc., Penumbra, Inc., Evasc, Neuravi, Sensome, Delaware Corporation, Gynesonics, Stryker, Johnson & Johnson Services, Inc., Abbott, Medikit co., ltd., MicroPort Scientific Corporation, Rapid Medical, W. L. Gore & Associates, Inc., Blockade Medical, LLC., OxfordEndovascular, and Secant Group, LLC. A majority of these market participants are actively focusing on expanding market presence by engaging in merger & acquisition and reaching offshore distribution agreements with third party vendors. 

Read More @ https://www.marketresearchfuture.com/reports/neurovascular-devices-market-5544

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Global Analysis on Global Microdermabrasion Devices Market Opportunities 2017-2023

 Microdermabrasion Market Scenario

Microdermabrasion is a minimal invasive technique involving spraying of tiny crystal for removal of thicker and even outer layer of skin. The microdermabrasion treatment diminished fine lines, wrinkles, acne scars, reducing the appearance of superficial pigmentation and sun damage. This procedure helps in thickening of collagen which results in younger skin complexion.

According to the American Society of Plastic Surgeon in 2015, nearly 15.9 million surgical and minimally invasive procedures were carried out in United States. The increasing demand for non-invasive cosmetics procedures is key driver to upsurge the market growth. Moreover, there is growing demand for microdermabrasion devices owing to more awareness and consciousness in people about their looks. Attraction of the youth towards western lifestyle and extensive use of cosmetics for skin care accelerate the growth of the market. 

Get Latest Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/5467

Apart from this, advantages like quick recovery, less time consumption and better results boosts the market growth. Additionally, development of new technologically advanced devices, and increasing demand for cosmetics also influence the growth of the market. 

The availability of alternative treatments like vibraderm, exfoliating products, chemical peels, photo abrasion and laser resurfacing are major restraints in market growth. On the other hand, factors such as high procedural costs and risks of side effects followed by increasing use of the lasers in dermatology will retrain the market growth during the 2017 to 2023. 

The global microdermabrasion market is approximate to reach USD 802.44 million by 2023 from USD 609.79 million in 2016 at a CAGR of 3.42% from 2017 to 2023.

Global Microdermabrasion Market –Competitive Landscape

The global microdermabrasion market is observed to be growing due to increasing developments by the prominent players in this market like Johnson & Johnson Services Inc., Procter & Gamble, Altair Instruments, Derma TX and other companies which boosts global microdermabrasion market. The key players in this market focuses on strategy to maintain its position in this market such as use of advanced technology for developing products, tie-ups with online portals and collaborations with other companies.

April, 2017 Johnson & Johnson announced tie-up with online portal aCommerce for selling company’s skincare product brands Neutrogena and Aveeno skincare. This collaboration helped the company to increase its skincare market in Philippines.

January, 2017 Derma TX Advanced skin care launched a microdermabrasion system for treatment of specific skincare issue. This launch aided rise in the company’s business in cosmeceutical skincare products.

March, 2014 Proctor & Gamble Beauty scientists offered insights into new ingredient formulation and effective skin care routines at 72nd Annual Meeting of the American Academy of Dermatology (AAD). Proctor & Gamble researchers showcased advanced studies in skincare technologies which included topics like cellular bioenergetics, anti-aging technologies, sensitive body wash efficiency and microdermabrasion systems.

Regional Analysis

The Americas is leading region in global microdermabrasion market owing to increasing prevalence of skin diseases such as acne, rising demands for outpatient and minimally invasive microdermabrasion procedures, and growing expenses on the cosmetics within this region.

The European region holds second largest market share in the global microdermabrasion market due to increasing incidence of skin related problems and increasing demand for anti-wrinkle and anti-aging treatments. Additionally, growing awareness about use of advanced technologies for skincare and rising healthcare expenditure facilities boosts the market growth in this region.

The Asia Pacific is the fastest growing market due to increased consumer awareness about aesthetic skin care treatment and growing demand for minimally invasive procedures and the growing prevalence of dermal conditions fuels the market growth in this region. Further, increasing prevalence and growing incidence of conditions of hyperpigmentation, stretch marks, and others fuels the market growth in this region.

The Middle East and Africa is the least growing market due to lack of awareness about microdermabrasion procedure and presence of poor countries especially in African region. The Middle East dominates the market in this region owing to huge healthcare expenditure and developed healthcare sector. Additionally, the presence of developed countries like Kuwait, Qatar and Saudi Arabia boosts the microdermabrasion market in this region.

Read More @ https://www.marketresearchfuture.com/reports/microdermabrasion-market-5467 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Global Analysis on Medication Management Market Size, trends and Demand

 Medication Management system Market Size, Share, Analysis and Trends

Market Insights

Market Research Future predicted that the global Medication Management system Market is set to reach the highest CAGR of 13.4% through the forecast period, 2018-2023.

Medication management focuses on improving medication use for the patient's condition. Interventions may include medication alignment, medication management, patient / family education about medications, and patient medication configuration simulations.

You can also read here!! https://www.medgadget.com/2020/01/medication-management-system-market-size-and-share-is-projected-to-grow-at-a-13-4-cagr-by-2023.html

The growing geriatric population is one of the most important factors in the drug management market. Older people often have significant comorbidities that increase drug use and the risk of poor outcomes. According to a 2018 study published in Clinical Epidemiology, polypharmacy affects between 40% and 50% of older people in countries with high-income. Polypharmacy increases the risk of drug-related side effects in older people because more drugs are associated with a higher risk of harmful drug interactions. Several other factors, such as the emergence of funds in the healthcare sector and the need to reduce healthcare costs, are some of the drivers of the market.

However, the high costs of software implementation and service maintenance can hinder the market growth during the forecast period.

Regional Outlook

The United States has dominated the global drug management market. This growth can be ascribed to the rise in the elderly population and the presence of the main market players in the region.

Europe ranked second in 2017 due to the presence of developed economies such as the United Kingdom, Germany, France, and other countries in the region, which is an engine for market growth.

The Asia Pacific region is likely to see the fastest growth in 2017. Factors such as health technology sector growth, increasing market penetration in the region, and growing government support for foreign investment provide regional markets in the region. Asia Pacific.

In addition, the Middle East and Africa had the lowest share of the global drug management market due to the existence of low per capita income and poor economies, especially in the African region. The Middle East region is considered an important market for the Middle East and Africa region.

Market Segmentation

The global Medication management marketis segmented based on systems, services, delivery methods, and end-user.

The global system-based medication management market is divided into computerized physician order entry systems, clinical decision support systems, administration software, inventory management systems, automated dispensing systems, and assurance systems. Administration software segment is further classified as Bar Code Drug Delivery Software (BCMA) and Electronic Drug Management Software (eMAR). The automatic distributor's segment is further classified as centralized automated distribution systems and decentralized automated distribution systems (ADS). A centralized automated dosing system includes robots / dosing systems and automated carousels. The decentralized automated dispensing system (ADS) comprises automated decentralized unit dose metering systems, pharmacy-based decentralized automated dispensing systems, and service-based decentralized automated dispensing systems.

The services market segment is subdivided into point-of-care verification services and drug side effects monitoring.

The global market, on the basis of delivery mode, is divided into on-premise solutions, web-based solutions, and cloud-based solutions.

The market is segmented into pharmacies, hospitals, healthcare facilities, research institutes, and others, based on end-user.

 

Major Players

The leading players that are supporting the functioning of the global medication management market include General Electric Company, Siemens Ltd, Medical Information Technology, QuadraMed Affinity Corporation, Allscripts Healthcare Solutions, Cerner Corporation, Mckesson Corporation, Omnicell, Inc., Carefusion Corporation, Epic Systems Corporation, and Optum Inc.

Recent Updates

• Omnicell, Inc., a leading  of medication management solutions for healthcare and pharmacy systems, has announced that Mercy, one of five US healthcare systems for Oklahoma, Arkansas, Missouri, and Kansas, will take over the management of medication in your service network through its Omnicell's automation and intelligence solutions. Omnicell works with major healthcare systems, such as Mercy, and the company launches its vision for independent pharmacies, a step-by-step plan for developing a fully automated zero-error drug management infrastructure. Based on automation, data intelligence, and specialized services, the autonomous pharmacy will allow pharmacists, nurses, physicians, and pharmacist staff to focus on patient and physician satisfaction.

Read More @ https://www.marketresearchfuture.com/reports/medication-management-market-7187 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

CAGR 6.9% Growth Predicted in Ligation Devices Market by 2024 with Top Leading Players and Technology

 Global Ligation Devices Market Report: By Product (Handheld Instruments, Accessories), Procedure (Minimally Invasive Surgery, Open Surgery), and Application (Gastrointestinal and Abdominal, Gynecological, Urological Applications)—Global Forecast till 2024

Market research future will be publishing a Half cooked research report on “Global ligation devices industry trends” that contains the information from 2019 to 2024. Ligation Devices Market is expected to grow at a CAGR 6.7% during the forecast period of 2019 to 2024.

Request Free Sample @ https://www.marketresearchfuture.com/sample_request/7794 

Market Research Future (MRFR) recognizes the following companies as the key players in the global Ligation Devices Market that includes Medtronic, Johnson & Johnson, The Cooper Companies, Inc., Conmed Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Olympus Corporation, Applied Medical Resources Corporation, Grena Think Medical, Genicon, Inc.

Key Players

Some of the key players in the global ligation devices market are Medtronic, Johnson & Johnson, The Cooper Companies, Inc., Conmed Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Olympus Corporation, Applied Medical Resources Corporation, Grena Think Medical, Genicon, Inc., and others.

Market Highlights
Ligation devices are used during surgeries for closing incisions or to join separated organs/tissue parts. Favorable reimbursement policies, rising healthcare expenditure, an increasing number of surgeries, and growing research and development expenditures are the factors driving the market growth. According to the Centers for Disease Control and Prevention in 2017, Coronary heart disease (CHD) was estimated to be the most common type of heart disease within the US and was projected to cause 370,000 per year. However, the high cost of surgery and related side effects are estimated to restraint the market growth.

Segmentation
The global ligation devices market is segmented based on product, procedure, application, end user, and region.

On the basis of product, the market is segmented into handheld instruments and accessories. Based on procedure, the market is segmented into minimally invasive surgery and open surgery. The application segment is segmented into gastrointestinal and abdominal applications, cardiovascular applications, gynecological applications, urological applications, and others. Based on the end user, the market is segmented into hospitals & clinics, ambulatory surgical center, and others.

Regional Analysis

The Americas dominated the global ligation devices market in 2018. Factors such as increasing healthcare expenditure and the rising incidence of chronic diseases are the major drivers within the region.

In 2018, it was estimated that Europe stood second in the global ligation devices market owing to increasing awareness, government support, development of technologically advanced medical products, and a growing number of surgeries. Moreover, the presence of developed economies (Germany, France, UK) boosts the market growth.

Asia-Pacific was the fastest growing region for the global ligation devices market in 2018. Factors such as increasing healthcare infrastructure, favorable government policies, an increasing number of surgeries and rising medical tourism drive the market growth within the region. According to the Indian Brand Equity Foundation in 2017, the Indian healthcare sector was estimated to be one of the fastest growing industries and is estimated to reach USD 280 billion by 2020 with a CAGR of 22.87% from 2015.

On the other hand, the Middle East and Africa held the least share in the global ligation devices market. Factors such as the presence of poor economies and low per capita income, especially within the African region make the market to lag within the region.

Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/ligation-devices-market-7794

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

size share global Covid19 Impact on Lab-on-a-Chip Market size research key companies review forecast to 2023

 Lab-on-a-Chip Device Market Information: Product (Instruments, Reagents & Consumables), Technology (Microarrays, Microfluidics), Application (Point of Care Diagnostics), and End-User (Biotechnology and Pharmaceutical Companies) – Global Forecast Till 2023

Market Highlights

The Lab-on-a-Chip Market size is forecasted to exhibit robust growth registering a CAGR of 10% during the forecast period. The global Lab-on-a-Chip Market size is majorly driven by increasing application of lab on chip devices in the medical field in the diagnosis of various infectious diseases which eases sample handling and yields efficient results in a snap of time. Similarly, the use of lab-on-a-chip devices in research purposes is gaining traction due to easy portability, automated biochemical assays, and huge sample handling provision. Moreover, rising demand for miniature devices, advancing fabrication technology, research on biosensors and biomarkers, and economic feasibility of lab-on-a-chip devices are expected to spur the market growth. However, initial higher purchasing rate, as well as lack of awareness about the use of lab-on-a-chip devices in middle-income countries, are major restraints to the market growth.

Read More Here!! https://www.medgadget.com/2018/07/lab-on-a-chip-device-market-10-cagr-exhibit-robust-growth-with-top-10-players-by-2023-exclusively-available-at-marketresearchfuture-com.html

Regional Analysis

Americas is the market leader and has an attractive market for lab on chip devices owing to increasing advances in molecular biology and genetic engineering techniques as well as increasing prevalence of infectious diseases.  Additionally, factors such as increasing number of genomic and proteomics research labs government initiatives and funding for research, development of advanced medical treatment options, and rising demand for portable devices are likely to enhance the growth of Lab-on-a-Chip Market size in the American region. For instance, According to stats presented in the Centers for Disease Control and Prevention report in the year 2017, around 49.9% of the children between the ages of 6 months to 17 years in the U.S. received an influenza vaccine. Due to the alarming rate of chronic as well as infectious diseases, use of lab-on-a-chip devices is accelerated due to its precision in diagnosis and multiple samples handling feature.

Europe is the second largest market and holds a healthy share in the global Lab-on-a-Chip Market size due to major driving factors such as the flourishing medical device market, favorable government initiatives to promote life-science and clinical research, rising average per capita income of individuals. For instance, the European Commission stated that the R&D spending by the pharmaceuticals and biotechnology sectors grew by 8.7% in 2014. This investment in R&D along with the ongoing legislative reforms is expected to have a positive impact on the Lab-on-a-Chip Market size.

The Asia-Pacific is expected to be the fastest growing market owing to the faster adaptation of healthcare technology, increasing patient pool of chronic and infectious diseases, government initiatives of healthcare reform, increasing number of CROs and research projects on environmental issues. Furthermore, key medical device players have set up their regional headquarters and manufacturing plants in Singapore, China, Japan,  and Australia thus, boosting the growth of Lab-on-a-Chip Market size.

The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access and availability of treatment facilities. In the Middle East, the United Arab Emirates is the largest market share owing to the development of the healthcare industry and sound economic status of inhabitants. However, this area has the possibility to grow during the forecast period as due to increasing outbreak of new opportunistic pathogen associated diseases like Ebola, Zika Virus, and Hepatitis B which has attracted key players to set up their R&D centers in this region.

Access Report @ https://www.marketresearchfuture.com/reports/lab-on-a-chip-device-market-6215

Industry Trends:

A Scotland based company uFraction8 Ltd. has recently come up with a microfluidic-based filtration system which is an essential part in remodeling the LoCs. Other innovations are also startling and can revolutionize the segment by taking the practice some light years ahead. Researchers from the Brigham Young University have now developed a technology that can 3D print LoC.

Segmentation:

The global LoC device market can be segmented by product, technology, application, and end-user. 

Product-wise, the market includes instruments, reagents & consumables, software, and others. Researchers from Biozentrum of the University of Basel and Max Planck Institute in Dresden have set up a LoC along with automatic analysis software that can study single cell responses. 

Based on application, the market comprises genomics, proteomics, the point of care diagnostics, drug discovery and others. LoC has revamped genomic field of study by taking down the time of detection by a considerable margin. Researchers from Griffith University’s Queensland Micro and Nanotechnology Centre have discovered new ways to screen drugs by using LoC that would reduce the drug testing time considerably.

By end-user, the market consists, hospitals and clinics, biotechnology and pharmaceutical companies, forensic laboratories, diagnostics centers, and academic & research institutes.

 

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:                                    

Akash Anand                                                                        

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com